F
Fengchuan Capital
Beijing
Overview
Fengchuan Capital is a private equity investment fund established in 2015, focusing on investments in the life sciences and healthcare industries, including innovative biopharmaceuticals, medical devices, and medical services.
Year Founded
2015
Portfolio Companies
4
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beijing WellGene Biotech Co., Ltd. | May 2023 | Series C | Co-investor |
| 4B Technologies | Feb 2021 | Series A Extension | Co-investor |
| Beijing WellGene Biotech Co., Ltd. | Nov 2020 | Series B | Co-investor |
| 上海赛默罗生物科技有限公司 | Nov 2018 | Series A | Co-investor |
| Degron Therapeutics | - | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
